{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T04:10:32Z","timestamp":1770178232646,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Densitometry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jocd.2025.101642","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T22:42:00Z","timestamp":1762209720000},"page":"101642","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The relationship between changes in calcium concentration and bone mineral density by anti-bone resorptive therapy"],"prefix":"10.1016","volume":"29","author":[{"given":"Akira","family":"Horikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7008-675X","authenticated-orcid":false,"given":"Yuji","family":"Kasukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michio","family":"Hongo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihisa","family":"Sano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5175-3350","authenticated-orcid":false,"given":"Naohisa","family":"Miyakoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocd.2025.101642_bib0001","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(10)62344-6","article-title":"Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study","volume":"377","author":"Fizazi","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jocd.2025.101642_bib0002","doi-asserted-by":"crossref","DOI":"10.1186\/s12894-018-0393-9","article-title":"Hypocalcemia in patients with prostate cancer treated with a bisphosphonate or denosumab: prevention supports treatment completion","author":"Body","year":"2018","journal-title":"BMC Urol"},{"key":"10.1016\/j.jocd.2025.101642_bib0003","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1177\/1078155218820927","article-title":"Effect of denosumab versus zoledronic acid on calcium levels in cancer patients with bone metastasis: a retrospective cohort study","volume":"25","author":"Nasser","year":"2019","journal-title":"J Oncol Pharm Practice"},{"key":"10.1016\/j.jocd.2025.101642_bib0004","article-title":"Symptomatic hypocalcemia associated with zoledronic acid treatment for osteoporosis: a case report","author":"Abdulmohsen","year":"2013","journal-title":"Oman Med J"},{"key":"10.1016\/j.jocd.2025.101642_bib0005","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00774-018-0928-x","article-title":"Potential association with early changes in serum calcium level after starting or switching to denosumab combined with eldecalcitol","volume":"37","author":"Asano","year":"2019","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.jocd.2025.101642_bib0006","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1007\/s00198-010-1448-2","article-title":"Effect of acetaminophen and fluvastatin on post-dose symptoms following infusion of zoledronic acid","volume":"22","author":"Silverman","year":"2011","journal-title":"Osteoporosis Int"},{"key":"10.1016\/j.jocd.2025.101642_bib0007","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1210\/jc.2010-0597","article-title":"Characterization of and risk factors for the acute-phase response after zoledronic acid","volume":"95","author":"Reid","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2025.101642_bib0008","doi-asserted-by":"crossref","DOI":"10.1007\/s00774-021-01221-6","article-title":"Short-term efficacy and safety of zoledronate acid or denosumab in Japanese patients with postmenopausal osteoporosis","author":"Nakamura","year":"2021","journal-title":"J Bone Mineral Metab"},{"key":"10.1016\/j.jocd.2025.101642_bib0009","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s00774-023-01410-5","article-title":"Safety and effectiveness of once yearly zoledronic acid in Japanese osteoporosis patients: three-year post-marketing surveillance","volume":"43","author":"Takada","year":"2023","journal-title":"J Bone Mineral Metab"},{"key":"10.1016\/j.jocd.2025.101642_bib0010","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1002\/jbmr.119","article-title":"Efficacy and safety of a once-yearly i.v. infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: a randomized, multicenter, double-blind active-controlled study","volume":"25","author":"Orwoll","year":"2010","journal-title":"J Bone Mineral Res"},{"key":"10.1016\/j.jocd.2025.101642_bib0011","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2014.13979","article-title":"Bisphosphonate induced hypocalcemia-report of six cases and review of the literature","author":"Kreutle","year":"2014","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.jocd.2025.101642_bib0012","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s00223-021-00884-7","article-title":"Acute phase reactions after intravenous infusion of zoledronic acid in Japanese patients with osteoporosis: Sub-analysis of the phase III zone study","volume":"109","author":"Shiraki","year":"2021","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.jocd.2025.101642_bib0013","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1210\/jc.2013-4175","article-title":"Clinical trials express: fracture risk reduction with denosumab in Japanese postmenopausal women and men with osteoporosis: denosumab fracture intervention randomized placebo-controlled trial (DIRECT)","volume":"99","author":"Nakamura","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2025.101642_bib0014","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11657-020-00733-4","article-title":"Adherence to and persistence with zoledronic acid treatment for osteoporosis- reasons for early discontinuation","volume":"15","author":"Spangeus","year":"2020","journal-title":"Arch Osteoporosis"},{"key":"10.1016\/j.jocd.2025.101642_bib0015","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s40261-012-0041-1","article-title":"Intravenous bisphosphonates for postmenopausal osteoporosis: Safety profiles of zoledronic acid and ibandronate in clinical practice","volume":"33","author":"Sieber","year":"2013","journal-title":"Clin Drug Inv"},{"key":"10.1016\/j.jocd.2025.101642_bib0016","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1007\/s00198-017-3992-5","article-title":"Factors associated with acute-phase response of bisphosphonate-na\u00efve or pretreated women with osteoporosis receiving an intravenous first dose of zoledronic acid or ibandronate","volume":"28","author":"Pop","year":"2017","journal-title":"Osteoporosis Int"},{"key":"10.1016\/j.jocd.2025.101642_bib0017","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/os.12338","article-title":"Multicenter study on observation of acute-phase response after infusion of zoledronic acid 5mg in Chinese women with postmenopausal osteoporosis","volume":"9","author":"Ding","year":"2017","journal-title":"Orthopedic Surg"},{"key":"10.1016\/j.jocd.2025.101642_bib0018","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1507\/endocrj.45.191","article-title":"A placebo-controlled single blind study to determine the alendronate dosage in postmenopausal Japanese patients with osteoporosis","volume":"45","author":"Shiraki","year":"1998","journal-title":"Endocrine J"},{"key":"10.1016\/j.jocd.2025.101642_bib0019","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00198-014-2964-2","article-title":"Three-year denosumab treatment in postmenopausal Japanese women and men with osteoporosis: results from a 1-year open-label extension of the denosumab fracture intervention randomized placebo controlled trial (DIRECT)","volume":"26","author":"Sugimoto","year":"2015","journal-title":"Osteoporosis Int"},{"key":"10.1016\/j.jocd.2025.101642_bib0020","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1007\/s00774-020-01119-9","article-title":"Efficacy of denosumab co-administrated with vitamin D and Ca by baseline vitamin D status","volume":"38","author":"Sugimoto","year":"2020","journal-title":"J Bone Mineral Metab"},{"key":"10.1016\/j.jocd.2025.101642_bib0021","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Eng J Med"},{"issue":"7","key":"10.1016\/j.jocd.2025.101642_bib0022","first-page":"513","article-title":"10 years of denosumab treatment in postmenopausal women with osteoporosis results from the phase 3 randomized FREEDOM trial and open-label extension","volume":"5","author":"Bone","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jocd.2025.101642_bib0023","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N Eng J Med"},{"key":"10.1016\/j.jocd.2025.101642_bib0024","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/jbmr.1494","article-title":"The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-pivotal fracture trial (PET)","volume":"27","author":"Black","year":"2012","journal-title":"J Bone and Miner Res"}],"container-title":["Journal of Clinical Densitometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695025000800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695025000800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T16:12:01Z","timestamp":1770135121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094695025000800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1094695025000800"],"URL":"https:\/\/doi.org\/10.1016\/j.jocd.2025.101642","relation":{},"ISSN":["1094-6950"],"issn-type":[{"value":"1094-6950","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relationship between changes in calcium concentration and bone mineral density by anti-bone resorptive therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Densitometry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocd.2025.101642","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The International Society for Clinical Densitometry. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101642"}}